INTRAMOLECULAR C-GLYCOSIDATION OF SUBSTITUTED SUGARS

取代糖的分子内 C-糖苷化

基本信息

  • 批准号:
    3295322
  • 负责人:
  • 金额:
    $ 7.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1987
  • 资助国家:
    美国
  • 起止时间:
    1987-07-01 至 1990-06-30
  • 项目状态:
    已结题

项目摘要

A novel methodology for the stereospecific synthesis of C- glycosides is proposed. This methodology is based on the preliminary attachment of a substituent containing a latent carbon-nucleophilic function to one of the hydroxyl function of a cyclic sugar derivative, followed by the creation of a carbon- carbon bond between this group and the anomeric center of the sugar. Thus, O-benzylated, N-benzylated and O-phenylated sugars should lead to "internal" C-glycosides (isochromans, tetrahydroisoquinolines and 2,3-dihydrobenzofurans resp.) which could be cleaved to C-glycosylated benzene derivatives or further elaborated (for example into tetrahydroisoquinoline alkaloids). The one-step transfer of a C-nucleophile might be achieved using a difunctional silyl derivative as a temporary linkage to the sugar- hydroxyl function: thus O-aryloxysilyl, as well as O-aryl-and O- allyl-dimethylsilyl carbohydrate derivatives are expected to undergo intra-molecular C-glycosidation with simultaneous cleavage of the auxiliary linkage upon treatment with a Lewis acid, thereby providing a highly efficient and general method of stereospecific C-glycosidation. This methodology will be used for the synthesis of a number of biologically and pharmacologically significant structures. Thus a series of arabino nucleoside analogs, in particular the dideaza analog of ara-C, one of the most potent agents against acute leukemia, benzenoid analogs of cyclouridine and cyclocytidine, as well indole C-nucleosides related to the antiviral agent are-A will be prepared by the intramolecular C-glycosylation of suitably substituted benzene and indole derivatives. The proposed methodology provides also a short approach to natural internal C- glycosides such as bergenin and related compounds, as well as to C-glycosyl flavonoids. Furthermore, N-benzylated amino sugars are precursors of chiral tetrahydroisoquinolines which have an extremely interesting substitution pattern because of its relation to that of tetra-hydroisoquinolines derived from biogenic amines and certain psychopharmacological drugs. C-benzylation of the corresponding N-benzylidene imino sugars, expected to be highly stereoselective, gives an intermediate which should lead in one step, by a "double intramolecular C-arylation" process, to the skeleton of the isopavine alkaloids. These reactions provide a short synthetic route from carbohydrates to chiral tetra- hydroisoquinoline alkaloids.
一种立体定向合成C- 糖基化被提出。 该方法基于 含有潜在的取代基的初步连接 碳-亲核官能团连接到 环糖衍生物,然后是碳- 该基团和异头中心之间的碳键 糖 因此,O-苄基化、N-苄基化和O-苯基化的糖 应该导致"内部" C-糖苷(异色满, 四氢异喹啉和2,3-二氢苯并呋喃)这 可以裂解成C-糖基化苯衍生物或进一步 精制(例如,制成四氢异喹啉生物碱)。 C-亲核试剂的一步转移可以使用 作为与糖的临时连接的双官能甲硅烷基衍生物, 羟基官能团:因此是O-芳氧基甲硅烷基,以及O-芳基-和O- 预期烯丙基-二甲基甲硅烷基碳水化合物衍生物 进行分子内C-糖苷化,同时 用刘易斯处理时辅助键的断裂 酸,从而提供了高效和通用的方法, 立体特异性C-糖苷化。 这一方法将用于综合若干 具有生物学和生物学意义的结构。 因此 一系列阿拉伯核苷类似物,特别是二脱氮 阿糖胞苷的类似物,一种最有效的抗急性 白血病,环胞苷和环胞苷的苯型类似物,如 那么吲哚C-核苷类相关的抗病毒剂是-A将 通过适当的分子内C-糖基化来制备 取代的苯和吲哚衍生物。 拟议 方法也提供了一个简短的方法,自然的内部C- 糖苷如岩白菜素和相关化合物,以及 C-糖基类黄酮。 此外,N-苄基化氨基糖 是手性四氢异喹啉的前体, 非常有趣的替代模式,因为它的关系 衍生自生物胺的四氢异喹啉 和某些精神药物 C-苄基化 相应的N-亚苄基亚氨基糖,预计高度 立体选择性,得到一种中间体, 步骤,通过"双分子内C-芳基化"过程, 异罂粟碱生物碱的骨架。 这些反应提供了 从碳水化合物到手性四氢呋喃的短合成路线 氢异喹啉生物碱。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OLIVIER R MARTIN其他文献

OLIVIER R MARTIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OLIVIER R MARTIN', 18)}}的其他基金

SMALL INSTRUMENTATION GRANT
小型仪器补助金
  • 批准号:
    3524226
  • 财政年份:
    1991
  • 资助金额:
    $ 7.22万
  • 项目类别:
SMALL INSTRUMENTATION PROGRAM
小型仪器项目
  • 批准号:
    3524048
  • 财政年份:
    1988
  • 资助金额:
    $ 7.22万
  • 项目类别:
INTRAMOLECULAR C-GLYCOSIDATION OF SUBSTITUTED SUGARS
取代糖的分子内 C-糖苷化
  • 批准号:
    3295325
  • 财政年份:
    1987
  • 资助金额:
    $ 7.22万
  • 项目类别:
INTRAMOLECULAR C-GLYCOSIDATION OF SUBSTITUTED SUGARS
取代糖的分子内 C-糖苷化
  • 批准号:
    3295324
  • 财政年份:
    1987
  • 资助金额:
    $ 7.22万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL EVALUATION OF C-DISACCHARIDES
C-二糖的合成和生物学评价
  • 批准号:
    2139638
  • 财政年份:
    1985
  • 资助金额:
    $ 7.22万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL EVALUATION OF C-DISACCHARIDES
C-二糖的合成和生物学评价
  • 批准号:
    3154187
  • 财政年份:
    1985
  • 资助金额:
    $ 7.22万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL EVALUATION OF C-DISACCHARIDES
C-二糖的合成和生物学评价
  • 批准号:
    3234018
  • 财政年份:
    1985
  • 资助金额:
    $ 7.22万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL EVALUATION OF C-DISACCHARIDES
C-二糖的合成和生物学评价
  • 批准号:
    2139637
  • 财政年份:
    1985
  • 资助金额:
    $ 7.22万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL EVALUATION OF C-DISACCHARIDES
C-二糖的合成和生物学评价
  • 批准号:
    3234012
  • 财政年份:
    1985
  • 资助金额:
    $ 7.22万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL EVALUATION OF C-DISACCHARIDES
C-二糖的合成和生物学评价
  • 批准号:
    3234017
  • 财政年份:
    1985
  • 资助金额:
    $ 7.22万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 7.22万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 7.22万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 7.22万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 7.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 7.22万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 7.22万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 7.22万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 7.22万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 7.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 7.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了